Page 230 - Full Immunisation Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Full immunisation coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Full Immunisation Coverage Today - Breaking & Trending Today

ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results


ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results
Recent Highlights and Accomplishments
Entered into a definitive merger agreement with Obalon Therapeutics, Inc., a company focused on developing and commercializing novel technologies for weight loss.
Strategic merger provides market synergies and the opportunity for the combined company to trade on NASDAQ.
Initiated enrollment of healthcare professionals in ReShapeCare
, the Company s first-in-class reimbursed, telehealth-based coaching program providing patients a tailored, high-touch, and personalized virtual treatment.
Received funding from a National Institutes of Health (NIH) Small Business Innovation Research grant to identify and successfully meet the necessary endpoints of a pre-clinical study with ReShape s Dual Block Stimulation Neuromodulation (DBSN) technology currently in development for the treatment of type 2 diabetes. ....

James Salierno , Thomas Stankovich , Truth Group , Small Business Innovation Research , Obalon Therapeutics Inc , Company Contact , National Institutes Of Health , Exchange Commission , Life Sciences Inc , Reshape Lifesciences , Obalon Therapeutics , National Institutes , Dual Block Stimulation Neuromodulation , Bart Bandy , Chief Executive Officer , Reshape Vest , Lap Band System , Investor Relations , Shape Lifesciences , Reshape Vest System , Reshapecare Virtual , Looking Safe Harbor Statement , Private Securities Litigation Reform Act , Nasdaq Capital Market , Ended December , Life Sciences ,

Shoals Technologies Group | Inc Announces Fourth Quarter and Full - Year 2020 Earnings Release Date and Conference Call


Shoals Technologies
Shoals
Technologies Group, Inc. (the Company ) (Nasdaq: SHLS) today announced that the company will release its fourth quarter and full - year 2020 results after the market close on Monday, March .
Shoals
Technologies Group, Inc. (the Company ) today announced that it has launched the roadshow for the initial public offering of its Class A common stock. The Company is offering 10,500,000 shares . ....

Shoals Technologies Group Inc , Shoalstechnologiesgroup Inc , Company Nasdaq , Shoals Technologies Group , Announces Fourth Quarter , Release Date , Conference Call , ஷோல்ஸ் தொழில்நுட்பங்கள் குழு இன்க் , நிறுவனம் நாஸ்டாக் , ஷோல்ஸ் தொழில்நுட்பங்கள் குழு , வெளியீடு தேதி , மாநாடு அழைப்பு ,

Materialise NV: Materialise Reports Fourth Quarter and Full Year 2020 Results


Materialise NV: Materialise Reports Fourth Quarter and Full Year 2020 Results
Highlights Fourth Quarter and Full Year 2020
Fourth Quarter 2020:
Total revenue was 45,301 kEUR, a decrease of 10.7% compared to the fourth quarter of 2019, but an increase of 11.1% compared to the third quarter of 2020.
Adjusted EBITDA was 7,370 kEUR; Adjusted EBITDA margin was 16.3%.
Net loss was (2,118) kEUR, or (0.04) EUR per diluted share, compared to 1,246 kEUR, or 0.03 EUR per diluted share, for the same period last year; the net loss was impacted by non-cash impairment charges and revaluations totaling (3,836) kEUR.
Full Year 2020:
Adjusted EBITDA was 20,378 kEUR in 2020, compared to 26,656 kEUR in 2019.
Total deferred revenue from annual software sales and maintenance contracts increased by 2,575 kEUR to 30,242 kEUR from 27,667 kEUR at the end of 2019. ....

Johan Albrecht , Wilfried Vancraen , Exchange Commission , Materialise Software , Exchange Rate , Securities Exchange , European Central Bank On , Ditto Inc , Fourth Quarter , Full Year , Chairman Peter Leys , Adjusted Ebitda , Materialise Manufacturing , Materialise Medical , European Central Bank , Chief Executive Officer , Peter Leys , Executive Chairman , Chief Financial , Securities Act , Securities Exchange Act , Net Profit , ஜோஹன் ஆல்பிரெக்ட் , பரிமாற்றம் தரகு , பரிமாற்றம் ரேட் , பத்திரங்கள் பரிமாற்றம் ,